Skip to main content

Table 2 Baseline characteristics of the study participants (N = 200)

From: STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications

Characteristic

n (%)1

Inclusion diagnosis

 

Affective psychosis

75 (38)

Bipolar disorder

63 (32)

Schizophrenia spectrum disorder

58 (29)

Post-traumatic stress disorder

4 (2)

Gender

 

Male

56 (28)

Female

144 (72)

Race2

 

White

171 (88)

Non-white

24 (12)

Hispanic ethnicity

4 (2)

Education

 

Less than high school

15 (8)

High school graduate/GED

46 (23)

Some college/technical school

87 (44)

College graduate

37 (19)

Post graduate

15 (8)

Marital status

 

Never married

57 (29)

Widowed/Divorced/Separated

57 (29)

Married

69 (34)

Living with partner

17 (9)

Annual household income

 

$0 - $9,999

54 (28)

$10,000 - $29,999

58 (30)

$30,000 – $49,999

34 (17)

$50,000 or higher

49 (25)

Number of people supported by income, mean (SD)

2.0 (1.3)

Employment status

 

Currently working

59 (30)

Disabled

71 (36)

Retired, unemployed, student, homemaker, temporarily laid off, or other

70 (35)

Atypical antipsychotic medication use

182 (91)

Medications taken that affect weight

 

≥1 that cause slight/moderate weight loss

77 (39)

≥1 that do not affect weight

168 (84)

≥1 that cause slight/moderate weight gain

21 (11)

≥1 that cause severe weight gain

128 (64)

Mood stabilizer medication use

97 (49)

Anti-depressant medication use

33 (17)

Smoked in the past year

65 (33)

Self-reported diabetes diagnosis

 

No

145 (73)

Yes

48 (24)

Don’t know

7 (4)

Self-reported hypertension diagnosis

 

No

114 (57)

Yes

70 (35)

Don’t know

15 (8)

 

Mean (SD)

Age—years

47.1 (10.7)

Weight—kg.3

107.7 (25.1)

Waist circumference—cm.3

113.9 (18.7)

Body mass index4

38.3 (8.3)

Blood pressure: systolic—mmHg

119.2 (14.7)

Blood pressure: diastolic—mmHg

79.4 (10.1)

Lipids

 

Triglycerides—mg/dL

188.0 (138.6)

LDL—mg/dL

101.4 (32.9)

HDL—mg/dL

45.8 (12.7)

Total cholesterol—mg/dL

181.6 (39.7)

Fasting glucose—mg/dL

108.9 (32.5)

Fasting insulinu—U/mL

13.0 (11.9)

Goal weight differential—kg.5

−31.7 (18.5)

Very likely to achieve goal weight, n (%)

33 (17)

Ideal weight differential—kg.6

−38.2 (21.5)

Very likely to achieve ideal weight, n (%)

21 (11)

Number of psychiatric medications

3.2 (1.5)

Psychiatric measures

 

CSI score7

19.3 (11.4)

BASIS-24 score8

1.37 (0.68)

SF36-GH score9

53.2 (21.3)

PAM13 (normed) score10

62.4 (16.0)

B-WISE score11

21.9 (3.6)

  1. 1Percentages reported use number of valid responses in the denominator. Percentages may not sum to 100% because of rounding.
  2. 2Race and ethnic groups were self-reported.
  3. 3To convert values for weight to pounds, multiply kilograms by 2.2. To convert values for centimeters to inches, multiply centimeters by 0.39.
  4. 4Body Mass Index is the weight in kilograms divided by the square of height in meters.
  5. 5The difference between self-reported goal weight and observed weight at baseline.
  6. 6The difference between self-reported ideal weight and observed weight at baseline.
  7. 7Colorado Symptom Index.
  8. 8Behavior and Symptom Identification Scale 24-item version.
  9. 9SF-36 General Health Subscale.
  10. 10Patient Activation Measure.
  11. 11Body Weight, Image and Self-Esteem Evaluation Questionnaire (B-WISE).